Testimony at New Jersey Regulatory Hearing in Defense of Pharmaceutical Marketing Research Howard Fienberg Government Affairs 10/20/2017 12:54:00 PM A leading research association testified at a hearing in New Jersey on October 19, 2017 about proposed regulations on payments to medical professionals, urging an exemption for pharmaceutical marketing research incentive payments. Read More
The Physician Payments Sunshine Act: The Insights Industry Position Howard Fienberg Government Affairs 10/28/2014 2:13:00 PM On August 1, 2013, the first reporting period under the Physician Payment Sunshine Act began. Part of the Patient Protection and Affordable Care Act (aka, “Obamacare”), it requires pharmaceutical and medical device manufacturers to publicly report many types of payments made to physicians, which will be public. The Sunshine Act was intended to bring transparency to these relationships, to minimize manufacturers’ influence on physicians’ prescribing behavior. Read More
New Texas health privacy law H.B. 300 more expansive than HIPAA Howard Fienberg Government Affairs 7/14/2011 6:33:00 PM Texas governor, Rick Perry, has signed a new health bill, H.B. 300, into law that enforces new obligations in addition to the requirements of the HIPAA privacy rule. The law, which becomes effective September 1, 2012, provides an expansive definition of a covered entity and is likely to include non-covered entities under HIPAA, including survey researchers. Read More